Expertise in
1
conditions

Dr. Stephan C. Sharp

Endocrinology
1916 Patterson St, Suite 710, 
Nashville, TN 
Expertise in
1
conditions
1916 Patterson St, Suite 710, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Stephan Sharp is an Endocrinologist in Nashville, Tennessee. Dr. Sharp is highly rated in 1 condition, according to our data. His top area of expertise is Carbuncle.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in TN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1916 Patterson St, Suite 710, Nashville, TN 37203

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults
A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
DIStinguish Respiratory Underlying Pathogen associaTed Host Response in Acute Respiratory Infection: An Evaluation of FebriDx POC Test
DIStinguish Respiratory Underlying Pathogen associaTed Host Response in Acute Respiratory Infection: An Evaluation of FebriDx POC Test
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Diagnostic test
Randomized, Active-Comparison, Double-Blind, Phase 2 Study to Assess the Safety and Immunogenicity of Anthrax Vaccine Adsorbed (BioThrax®) Without and With CPG 7909 Adjuvant (AV7909 Anthrax Vaccine), Using a Post-Exposure Prophylaxis Dosing Regimen in Adults 66 Years of Age or Older in Stable Health in Comparison to Adults 18-50 Years of Age in Stable Health
Randomized, Active-Comparison, Double-Blind, Phase 2 Study to Assess the Safety and Immunogenicity of Anthrax Vaccine Adsorbed (BioThrax®) Without and With CPG 7909 Adjuvant (AV7909 Anthrax Vaccine), Using a Post-Exposure Prophylaxis Dosing Regimen in Adults 66 Years of Age or Older in Stable Health in Comparison to Adults 18-50 Years of Age in Stable Health
Enrollment Status: Completed
Publish Date: July 21, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 5 Less Clinical Trials

2 Total Publications

A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever.
Journal: Annals of medicine
Published: May 19, 2018
Similar Doctors
Expertise in
29
conditions
Dr. Kathryn M. Dahir
Endocrinology
Expertise in
29
conditions
Dr. Kathryn M. Dahir
Endocrinology

Vanderbilt University Medical Center

1301 22nd Ave S, 
Nashville, TN 
 (1.0 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kathryn Dahir is an Endocrinologist in Nashville, Tennessee. Dr. Dahir is highly rated in 29 conditions, according to our data. Her top areas of expertise are Hypophosphatasia (HPP), X-Linked Hypophosphatemia, Osteomalacia, and Hypophosphatemia.

Expertise in
18
conditions
Dr. Lindsay A. Bischoff
Endocrinology
Expertise in
18
conditions
Dr. Lindsay A. Bischoff
Endocrinology

Vanderbilt University Medical Center

719 Thompson Ln, 
Nashville, TN 
 (3.9 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lindsay Bischoff is an Endocrinologist in Nashville, Tennessee. Dr. Bischoff is highly rated in 18 conditions, according to our data. Her top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy.

Expertise in
54
conditions
Dr. Andrea L. Utz
Endocrinology
Expertise in
54
conditions
Dr. Andrea L. Utz
Endocrinology

Vanderbilt University Medical Center

719 Thompson Ln, 
Nashville, TN 
 (3.9 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrea Utz is an Endocrinologist in Nashville, Tennessee. Dr. Utz is highly rated in 54 conditions, according to our data. Her top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Cushing's disease, and Prolactinoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sharp's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile